Genetic Risk Markers for Hepatocellular Carcinoma in Patients with Alcoholic Liver Disease

References

• Schoniger-Hekele M , MullerC, KutilekM, OesterreicherC, FerenciP, GanglA. Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation. Eur. J. Gastroenterol. Hepatol.12(8), 941–948 (2000).
   PubMed Web of Science ®Google Scholar
• Bosch Fx , RibesJ, DiazM, CleriesR. Primary liver cancer: worldwide incidence and trends. Gastroenterology127(5 Suppl. 1), S5–S16 (2004).
   PubMed Web of Science ®Google Scholar
• Bruix J , GoresGj, MazzaferroV. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut63(5), 844–855 (2014).
   PubMed Web of Science ®Google Scholar
• Davis Gl , AlterMj, El-SeragH, PoynardT, JenningsLw. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology138(2), 513–521, 521.e511–e516 (2010).
   PubMed Web of Science ®Google Scholar
• Lim SS , VosT, FlaxmanADet al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet380(9859), 2224–2260 (2012).
   PubMed Web of Science ®Google Scholar
• Morgan TR , MandayamS, JamalMM. Alcohol and hepatocellular carcinoma. Gastroenterology127(5 Suppl. 1), S87–S96 (2004).
   PubMed Web of Science ®Google Scholar
• Benvegnu L , NoventaF, BernardinelloE, PontissoP, GattaA, AlbertiA. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut48(1), 110–115 (2001).
   PubMed Web of Science ®Google Scholar
• Mair RD , ValenzuelaA, HaNBet al. Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies. Clin. Gastroenterol. Hepatol.10(12), 1412–1417 (2012).
   PubMed Web of Science ®Google Scholar
• Toshikuni N , IzumiA, NishinoKet al. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. J. Gastroenterol. Hepatol.24(7), 1276–1283 (2009).
   PubMed Web of Science ®Google Scholar
• Bell H , JahnsenJ, KittangE, RaknerudN, SandvikL. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand. J. Gastroenterol.39(9), 858–863 (2004).
   PubMed Web of Science ®Google Scholar
• Jepsen P , OttP, AndersenPK, SorensenHT, VilstrupH. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann. Intern. Med.156(12), 841–847, W295 (2012).
   PubMed Web of Science ®Google Scholar
• Mancebo A , Gonzalez-DieguezMl, CadahiaVet al. Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. Clin. Gastroenterol. Hepatol.11(1), 95–101 (2013).
   PubMed Web of Science ®Google Scholar
• N’kontchou G , PariesJ, HtarMTet al. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin. Gastroenterol. Hepatol.4(8), 1062–1068 (2006).
   PubMed Web of Science ®Google Scholar
• Trinchet JC , ChaffautC, BourcierVet al. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities. Hepatology54(6), 1987–1997 (2011).
   PubMed Web of Science ®Google Scholar
• Nahon P , Zucman-RossiJ. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis. J. Hepatol.57, 663–674 (2012).
   PubMed Web of Science ®Google Scholar
• Stickel F , HampeJ. Genetic determinants of alcoholic liver disease. Gut61(1), 150–159 (2011).
   PubMed Web of Science ®Google Scholar
• Druesne-Pecollo N , TehardB, MalletYet al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol.10(2), 173–180 (2009).
   PubMed Web of Science ®Google Scholar
• Lee MH , YangHI, LiuJet al. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Hepatology58(2), 546–554 (2013).
   PubMed Web of Science ®Google Scholar
• Nahon P , SuttonA, PessayreDet al. Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death. Clin. Gastroenterol. Hepatol.3(3), 292–298 (2005).
   PubMed Web of Science ®Google Scholar
• Dong LM , PotterJD, WhiteE, UlrichCM, CardonLR, PetersU. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA299(20), 2423–2436 (2008).
   PubMed Web of Science ®Google Scholar
• Seitz HK , StickelF. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer7(8), 599–612 (2007).
   PubMed Web of Science ®Google Scholar
• Della Corte C , AghemoA, ColomboM. Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies. World J. Gastroenterol.19(9), 1359–1371 (2013).
   PubMed Web of Science ®Google Scholar
• Homann N , StickelF, KonigIRet al. Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. Int. J. Cancer118(8), 1998–2002 (2006).
   PubMed Web of Science ®Google Scholar
• Sakamoto T , HaraM, HigakiYet al. Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population. Int. J. Cancer118(6), 1501–1507 (2006).
   PubMed Web of Science ®Google Scholar
• Munaka M , KohshiK, KawamotoTet al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol.129(6), 355–360 (2003).
   PubMed Web of Science ®Google Scholar
• Nahon P , SuttonA, RufatPet al. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology50(5), 1484–1493 (2009).
   PubMed Web of Science ®Google Scholar
• Nahon P , SuttonA, RufatPet al. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis. Gastroenterology134(1), 102–110 (2008).
   PubMed Web of Science ®Google Scholar
• Jin F , QuLS, ShenXZ. Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis. J. Exp. Clin. Cancer Res.29, 18 (2010).
   PubMed Web of Science ®Google Scholar
• Charni F , SuttonA, RufatPet al. Chemokine RANTES Promoter Dimorphisms and Hepatocellular Carcinoma Occurrence in Patients with Alcoholic or Hepatitis C Virus-Related Cirrhosis. Cancer Epidemiol. Biomarkers Prev.20(7), 1439–1446 (2011).
   PubMed Web of Science ®Google Scholar
• Falleti E , FabrisC, ToniuttoPet al. Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease. Oncology77(5), 304–313 (2009).
   PubMed Web of Science ®Google Scholar
• Saffroy R , PhamP, ChiappiniFet al. The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis25(8), 1443–1448 (2004).
   PubMed Web of Science ®Google Scholar
• Fabris C , ToniuttoP, FalletiEet al. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. Alcohol Clin. Exp. Res.33(1), 102–107 (2009).
   PubMed Web of Science ®Google Scholar
• Tanabe KK , LemoineA, FinkelsteinDMet al. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA299(1), 53–60 (2008).
   PubMed Web of Science ®Google Scholar
• Zhong JH , YouXM, GongWFet al. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis. PLoS ONE7(3), e32159 (2012).
   PubMed Web of Science ®Google Scholar
• Falleti E , FabrisC, CmetSet al. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver Int.31(8), 1137–1143 (2011).
   PubMed Web of Science ®Google Scholar
• Nischalke HD , BergerC, LudaCet al. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS ONE6(11), e27087 (2011).
   PubMed Web of Science ®Google Scholar
• Trepo E , GuyotE, Ganne-CarrieNet al. PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis. Hepatology55(4), 1307–1308 (2012).
   PubMed Web of Science ®Google Scholar
• Guyot E , SuttonA, RufatPet al. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. J. Hepatol.58(2), 312–318 (2013).
   PubMed Web of Science ®Google Scholar
• Trepo E , NahonP, BontempiGet al. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology59(6), 2170–2177 (2013).
   Web of Science ®Google Scholar
• Nischalke HD , LutzP, KramerBet al. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease. J. Hepatol.16, S0168–S8278 (2014).
   Google Scholar
• Duester G , FarresJ, FelderMRet al. Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. Biochem. Pharmacol.58(3), 389–395 (1999).
   PubMed Web of Science ®Google Scholar
• Bosron WF , EhrigT, LiTK. Genetic factors in alcohol metabolism and alcoholism. Semin. Liver Dis.13(2), 126–135 (1993).
   PubMed Web of Science ®Google Scholar
• Crabb DW , EdenbergHJ, BosronWF, LiTK. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. J. Clin. Invest.83, 314–316 (1989).
   PubMed Web of Science ®Google Scholar
• Sarsour EH , KumarMG, ChaudhuriL, KalenAL, GoswamiPC. Redox control of the cell cycle in health and disease. Antioxid. Redox Signal11(12), 2985–3011 (2009).
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ . Myeloperoxidase: friend and foe. J. Leukoc. Biol.77(5), 598–625 (2005).
   PubMed Web of Science ®Google Scholar
• Piedrafita FJ , MolanderRB, VansantG, OrlovaEA, PfahlM, ReynoldsWF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem.271(24), 14412–14420 (1996).
   PubMed Web of Science ®Google Scholar
• Osterreicher CH , DatzC, StickelFet al. Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis. J. Hepatol.42(6), 914–919 (2005).
   PubMed Web of Science ®Google Scholar
• Ahn J , GammonMD, SantellaRMet al. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res.64(20), 7634–7639 (2004).
   PubMed Web of Science ®Google Scholar
• Wallace DC . Mitochondrial diseases in man and mouse. Science283(5407), 1482–1488 (1999).
   PubMed Web of Science ®Google Scholar
• Sutton A , KhouryH, Prip-BuusC, CepanecC, PessayreD, DegoulF. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics13(3), 145–157 (2003).
   PubMedGoogle Scholar
• Sutton A , ImbertA, IgoudjilAet al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet. Genomics15(5), 311–319 (2005).
   PubMed Web of Science ®Google Scholar
• Perera CS , St ClairDK, McclainCJ. Differential regulation of manganese superoxide dismutase activity by alcohol and TNF in human hepatoma cells. Arch. Biochem. Biophys.323(2), 471–476 (1995).
   PubMed Web of Science ®Google Scholar
• Macmillan-Crow LA , CrowJP, ThompsonJA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry37(6), 1613–1622 (1998).
   PubMed Web of Science ®Google Scholar
• Yang M , CobinePA, MolikSet al. The effects of mitochondrial iron homeostasis on cofactor specificity of superoxide dismutase 2. EMBO J.25(8), 1775–1783 (2006).
   PubMed Web of Science ®Google Scholar
• Nahon P , CharnauxN, FriandVet al. The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells. Free Radic. Biol. Med.45(9), 1308–1317 (2008).
   PubMed Web of Science ®Google Scholar
• Lambrecht RW , SterlingRK, NaishadhamDet al. Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology140(5), 1490–1500e1493 (2011).
   PubMed Web of Science ®Google Scholar
• Korenaga M , WangT, LiYet al. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J. Biol. Chem.280(45), 37481–37488 (2005).
   PubMed Web of Science ®Google Scholar
• Choi J , LeeKJ, ZhengY, YamagaAK, LaiMM, OuJH. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology39(1), 81–89 (2004).
   PubMed Web of Science ®Google Scholar
• Fillebeen C , PantopoulosK. Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells. J. Hepatol.53(6), 995–999 (2010).
   PubMed Web of Science ®Google Scholar
• Bjelakovic G , NikolovaD, GluudLL, SimonettiRG, GluudC. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA297(8), 842–857 (2007).
   PubMed Web of Science ®Google Scholar
• Park EJ , LeeJH, YuGYet al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell140(2), 197–208 (2010).
   PubMed Web of Science ®Google Scholar
• Stauffer JK , ScarzelloAJ, JiangQ, WiltroutRH. Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology56(4), 1567–1574 (2012).
   PubMed Web of Science ®Google Scholar
• Chiba T , MarusawaH, UshijimaT. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology143(3), 550–563 (2012).
   PubMed Web of Science ®Google Scholar
• Yang Y , LuoC, FengR, BiS. The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J. Cancer Res. Clin. Oncol.137(6), 947–952 (2011).
   PubMed Web of Science ®Google Scholar
• Gleeson D , BradleyMP, JonesJet al. Cytokine gene polymorphisms in heavy drinkers with and without decompensated liver disease: a case–control study. Am. J. Gastroenterol.103(12), 3039–3046 (2008).
   PubMed Web of Science ®Google Scholar
• Marcos M , Gomez-MunueraM, PastorI, Gonzalez-SarmientoR, LasoFJ. Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am. J. Epidemiol.170(8), 948–956 (2009).
   PubMed Web of Science ®Google Scholar
• Tarhuni A , GuyotE, RufatPet al. Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis. J. Hepatol.61(2), 342–350 (2014).
   PubMed Web of Science ®Google Scholar
• Blanc P , EtienneH, DaujatMet al. Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum. Gastroenterology102(4 Pt 1), 1340–1350 (1992).
   PubMed Web of Science ®Google Scholar
• Schiffer E , HoussetC, CacheuxWet al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology41(2), 307–314 (2005).
   PubMed Web of Science ®Google Scholar
• Shahbazi M , PravicaV, NasreenNet al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet359(9304), 397–401 (2002).
   PubMed Web of Science ®Google Scholar
• Abu Dayyeh BK , YangM, FuchsBCet al. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology141(1), 141–149 (2011).
   PubMed Web of Science ®Google Scholar
• Boisvert J , KunkelEJ, CampbellJJ, KeeffeEB, ButcherEC, GreenbergHB. Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. J. Hepatol.38(1), 67–75 (2003).
   PubMed Web of Science ®Google Scholar
• Yoong KF , AffordSC, JonesRet al. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology30(1), 100–111 (1999).
   PubMed Web of Science ®Google Scholar
• Karnoub AE , DashAB, VoAPet al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature449(7162), 557–563 (2007).
   PubMed Web of Science ®Google Scholar
• Iida N , NakamotoY, BabaTet al. Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alpha. Cancer Res.70(16), 6556–6565 (2010).
   PubMed Web of Science ®Google Scholar
• Yuan JM , LuSC, Van Den BergDet al. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology46(3), 749–758 (2007).
   PubMed Web of Science ®Google Scholar
• Liu C , WangH, PanC, ShenJ, LiangY. CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls. Tumour Biol.33(4), 979–984 (2012).
   PubMedGoogle Scholar
• Xu Y , LiuL, LiuJet al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int. J. Cancer128(2), 412–417 (2011).
   PubMed Web of Science ®Google Scholar
• Romeo S , KozlitinaJ, XingCet al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet.40(12), 1461–1465 (2008).
   PubMed Web of Science ®Google Scholar
• Tian C , StokowskiRp, KershenobichD, BallingerDg, HindsDa. Variant in PNPLA3 is associated with alcoholic liver disease. Nat. Genet.42(1), 21–23 (2010).
   PubMed Web of Science ®Google Scholar
• Yuan X , WaterworthD, PerryJRet al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet.83(4), 520–528 (2008).
   PubMed Web of Science ®Google Scholar
• He S , McphaulC, LiJZet al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem.285(9), 6706–6715 (2010).
   PubMed Web of Science ®Google Scholar
• Sookoian S , PirolaCj. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology53(6), 1883–1894 (2011).
   PubMed Web of Science ®Google Scholar
• Speliotes EK , ButlerJL, PalmerCD, VoightBF, HirschhornJN. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology52(3), 904–912 (2010).
   PubMed Web of Science ®Google Scholar
• Valenti L , RumiM, GalmozziEet al. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology53(3), 791–799 (2011).
   PubMed Web of Science ®Google Scholar
• Trepo E , PradatP, PotthoffAet al. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology54(1), 60–69 (2011).
   PubMed Web of Science ®Google Scholar
• Stickel F , BuchS, LauKet al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology53(1), 86–95 (2011).
   PubMed Web of Science ®Google Scholar
• Trepo E , GustotT, DegreDet al. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J. Hepatol.55(4), 906–912 (2011).
   PubMed Web of Science ®Google Scholar
• Corradini SG , BurzaMA, MolinaroA, RomeoS. Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma. Hepatology53(5), 1776; author reply 1777 (2011).
   PubMed Web of Science ®Google Scholar
• Singal AG , ManjunathH, YoppACet al. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis. Am. J. Gastroenterol.109(3), 325–334 (2014).
   PubMed Web of Science ®Google Scholar
• Valenti L , Al-SerriA, DalyAKet al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology51(4), 1209–1217 (2010).
   PubMed Web of Science ®Google Scholar
• Nkontchou G , BastardJP, ZiolMet al. Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis. J. Hepatol.53(5), 827–833 (2011).
   Web of Science ®Google Scholar
• Pirazzi C , ValentiL, MottaBMet al. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. Hum. Mol. Genet.23(15), 4077–4085 (2014).
   PubMed Web of Science ®Google Scholar
• Fields AL , SopranoDR, SopranoKJ. Retinoids in biological control and cancer. J. Cell Biochem.102(4), 886–898 (2007).
   PubMed Web of Science ®Google Scholar
• Muto Y , MoriwakiH, SaitoA. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N. Engl. J. Med.340(13), 1046–1047 (1999).
   PubMed Web of Science ®Google Scholar
• Speliotes EK , Yerges-ArmstrongLM, WuJet al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet.7(3), e1001324 (2011).
   PubMed Web of Science ®Google Scholar
• Boyault S , RickmanDS, De ReyniesAet al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology45(1), 42–52 (2007).
   PubMed Web of Science ®Google Scholar
• Nault JC , De ReyniesA, VillanuevaAet al. A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. Gastroenterology145(1), 176–187 (2013).
   PubMed Web of Science ®Google Scholar
• Derambure C , CoulouarnC, CaillotFet al. Genome-wide differences in hepatitis C- vs alcoholism-associated hepatocellular carcinoma. World J. Gastroenterol.14(11), 1749–1758 (2008).
   PubMed Web of Science ®Google Scholar